Evidence map›Paper›PMID 29678105›Full record

ArticleACS chemical neuroscience2018

3-Substituted 1,5-Diaryl-1 H-1,2,4-triazoles as Prospective PET Radioligands for Imaging Brain COX-1 in Monkey. Part 1: Synthesis and Pharmacology.

Prachi Singh, Stal Shrestha, Michelle Y Cortes-Salva, Kimberly J Jenko, Sami S Zoghbi, Cheryl L Morse, Robert B Innis, Victor W Pike

Open access · greenAbstract read
In one paragraph

Article in ACS chemical neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. [Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Article
  4. A comprehensive review ofMedicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2026
    Review
  5. Synthetic Strategies to Access Fluorinated Azoles.European journal of organic chemistry · 2025
    Article
  6. Article
  7. Article
  8. [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Whole-Body PET Imaging in Humans Shows ThatJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2023
    Article
  14. Cyclooxygenases as Potential PET Imaging Biomarkers to Explore Neuroinflammation in Dementia.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022
    Review
  15. Review
  16. NRM 2021 Abstract Booklet.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021
    Article
  17. Is cyclooxygenase-1 involved in neuroinflammation?Journal of neuroscience research · 2021
    Review
  18. RepurposingJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2021
    Article
  19. Article
  20. Synthesis of [ACS chemical neuroscience · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Prachi SinghMolecular Imaging Branch , National Institute of Mental Health, National Institutes of Health , Building 10, Room B3 C346A, 10 Center Drive , Bethesda , Maryland 20892 , United States.
Stal ShresthaMolecular Imaging Branch , National Institute of Mental Health, National Institutes of Health , Building 10, Room B3 C346A, 10 Center Drive , Bethesda , Maryland 20892 , United States.
Michelle Y Cortes-SalvaMolecular Imaging Branch , National Institute of Mental Health, National Institutes of Health , Building 10, Room B3 C346A, 10 Center Drive , Bethesda , Maryland 20892 , United States.
Kimberly J JenkoMolecular Imaging Branch , National Institute of Mental Health, National Institutes of Health , Building 10, Room B3 C346A, 10 Center Drive , Bethesda , Maryland 20892 , United States.
Sami S ZoghbiMolecular Imaging Branch , National Institute of Mental Health, National Institutes of Health , Building 10, Room B3 C346A, 10 Center Drive , Bethesda , Maryland 20892 , United States.
Cheryl L MorseMolecular Imaging Branch , National Institute of Mental Health, National Institutes of Health , Building 10, Room B3 C346A, 10 Center Drive , Bethesda , Maryland 20892 , United States.
Robert B InnisMolecular Imaging Branch , National Institute of Mental Health, National Institutes of Health , Building 10, Room B3 C346A, 10 Center Drive , Bethesda , Maryland 20892 , United States.
Victor W PikeMolecular Imaging Branch , National Institute of Mental Health, National Institutes of Health , Building 10, Room B3 C346A, 10 Center Drive , Bethesda , Maryland 20892 , United States.ORCID 0000-0001-9032-2553
National Institutes of Health · US

Funding

PET Radiopharmaceutical SciencesZIAMH002793 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI PIKE, VICTOR W · 2009 to 2025
$69.8M
Translational Evaluation Of PET RadiotracersZIAMH002795 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI INNIS, ROBERT · 2009 to 2025
$32.0M
Intramural NIH HHS ZIA MH002793Intramural NIH HHS ZIA MH002795NIMH NIH HHS N01 MH032004
6 · The paper itself

Abstract

Cyclooxygenase-1 (COX-1) is a key enzyme in the biosynthesis of proinflammatory thromboxanes and prostaglandins and is found in glial and neuronal cells within brain. COX-1 expression is implicated in numerous neuroinflammatory states. We aim to find a direct-acting positron emission tomography (PET) radioligand for imaging COX-1 in human brain as a potential biomarker of neuroinflammation and for serving as a tool in drug development. Seventeen 3-substituted 1,5-diaryl-1 H-1,2,4-triazoles were prepared as prospective COX-1 PET radioligands. From this set, three 1,5-(4-methoxyphenyl)-1 H-1,2,4-triazoles, carrying a 3-methoxy (5), 3-(1,1,1-trifluoroethoxy) (20), or 3-fluoromethoxy substituent (6), were selected for radioligand development, based mainly on their high affinities and selectivities for inhibiting human COX-1, absence of carboxyl group, moderate computed lipophilicities, and scope for radiolabeling with carbon-11 ( t

Indexed as

AnimalsBrainCarbon RadioisotopesCyclooxygenase 1Cyclooxygenase InhibitorsFluorine RadioisotopesInflammationMacaca mulattaPositron-Emission TomographyRadiopharmaceuticalsRatsTriazolesCarbon-11Carbon RadioisotopesCyclooxygenase 1Cyclooxygenase InhibitorsFluorine-18Fluorine RadioisotopesRadiopharmaceuticalsTriazolesbraincarbon-11COX-1fluorine-18PETradioligand

Identifiers

PMID29678105
PMCPMC6744613
OpenAlexW2800703264

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.